The department of Radiation Oncology at Jaslok Hospital is one of the largest unit in a non government set-up. It offers varieties of treatment modalities to cater to the need of patients. The department has the following equipments.
ONCOR Expression Linear Accelerator with 82 MLC leaves. The machine is IMRT and IGRT capable. The IGRT solution is M-Vision. The unit is capable to deliver a very accurate and precise treatment plan for 3D-CRT and IMRT with 2D and 3D image guidance.
Primus Linear Accelerator with multileaf collimator generates 6 & 15 MV Photons and 6 stages of elections and takes the load of 3D-CRT and conventional radiotherapy. The Primus Linear Accelerator is capable of delivering Stereotactic radiotherapy using X-knife system.
The department is maintaining one Telecobalt unit (Theratron 780E) and the machine treats approx. 30 patients a day to share the load of two Linacs.
The department is equipped with a Conventional Simulator (Simview 2000) although a large number of patient undergo CT based planning with optional MRI & PET scan.
Brachytherapy is an integral part of treatment plan for many patients. MicroSelectron HDR is the remote-control after loading High Dose Rate Brachytherapy unit.
Majority of the patients treatment is planned in Treatment Planning System (TPS-computer). Jaslok has KonRad TPS for Inverse Planning (IMRT), CMS XiO specially for 3D-CRT, Helax TMS for routine planning and Plato for Brachytherapy Planning.
The "Local Area Networking Therapy Information System" (LANTIS) is used to capture patient related information including images and to transfer data into therapy management system. This makes the treatment electronically controlled which is faster and more accurate. LANTIS helps verifying treatment set-up, scheduling activities and producing quality control check list.
The department is managed by qualified and experienced professionals to offer high tech modern radiotherapy and provide advance and optimal radiotherapy which is as per with any of the well established centers.
|